These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model. Daher A; de Groot J Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369 [TBL] [Abstract][Full Text] [Related]
6. Management of glioblastoma: State of the art and future directions. Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924 [TBL] [Abstract][Full Text] [Related]
8. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance. Noch EK; Ramakrishna R; Magge R World Neurosurg; 2018 Aug; 116():505-517. PubMed ID: 30049045 [TBL] [Abstract][Full Text] [Related]
9. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
18. The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483 [TBL] [Abstract][Full Text] [Related]
19. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care. Habib A; Pease M; Kodavali CV; Amankulor N; Zinn PO J Neurooncol; 2021 Jan; 151(2):103-112. PubMed ID: 33394264 [TBL] [Abstract][Full Text] [Related]